Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm MacCoss

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|September 25, 2004
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesDavid B Olsen, Anne B Eldrup, Linda Bartholomew, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
The discovery of acylated beta-amino acids as potent and orally bioavailable VLA-4 antagonistsLinus S Lin, Ihor E Kopka, Richard A Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonistsIhor E Kopka, Linus S Lin, Richard A Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonistsIhor E Kopka, David N Young, Linus S Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
The Journal of Biological Chemistry|September 11, 2003
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitroGiovanni Migliaccio, Joanne E Tomassini, Steven S Carroll, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsFrank Bennett, Hollis S Kezar, Vinay Girijavallabhan, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|September 25, 2004
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic propertiesDavid B Olsen, Anne B Eldrup, Linda Bartholomew, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
The discovery of acylated beta-amino acids as potent and orally bioavailable VLA-4 antagonistsLinus S Lin, Ihor E Kopka, Richard A Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonistsIhor E Kopka, Linus S Lin, Richard A Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonistsIhor E Kopka, David N Young, Linus S Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
The Journal of Biological Chemistry|September 11, 2003
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitroGiovanni Migliaccio, Joanne E Tomassini, Steven S Carroll, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsFrank Bennett, Hollis S Kezar, Vinay Girijavallabhan, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Pageof 7